
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOUlktR2pLY0JiWFdHWWtNb2ozX2ltdUZPV0F3SlNud0o5aUF0Nk16bEZjTU9yWW1sd044bnlwYWxrM0pGaDE5TGRQS2hlWGNtbVJIOF8zNVpQOWF5S1FMUXdCeV85Y1oxOG9Dck9ydjZGcGN2czgxOE5aeFY5Y3BVVExITTZpY1JUbG9sMHYtZmpCRzZGa1dGNUJBR0JvTl9TRmZ6R0NxSdIBrAFBVV95cUxNSDhhdThuTXRTbkNHRzIzVklfb3M0S1pjWWFSNTBhal9GQlVWZzBZVkpDeEVlREc2eEYyNTRNSkdvSzZ3cVBQanc3S012LWZocFVoTXJNMHVJaHFNSFBlZG1vMFZ3eTk0NzhSUEdXSGR4QXY5N1o5Q1FPN3czNTFHOURrektERU02MFQxRmMtTDJrNFhDeEE5OHBFVHBHRzRCeGZZNjBjV3BNZmVY?oc=5" target="_blank">Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar</a>&nbsp;&nbsp;<font color="#6f6f6f">CNBC</font>

